SAN MATEO, Calif. and CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced ...

MALVERN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement ...

WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) is pleased to announce the election of H. Thomas Watkins, President & CEO of Human Genome Sciences, Inc, as its new Chairman ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced ...

Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity (PIPE) ...

CHICAGO--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) is pleased to announce the election of Rachel King, President and CEO, GlycoMimetics, Inc, as the new Chair of its Board of ...

WASHINGTON — The sprawling trade association for companies making everything from weed killer to CAR-T cancer therapies, the Biotechnology Innovation Organization, has new leadership. But it’s still ...

DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that its chairman, president and ...

John Crowley, the longtime leader of rare disease drug developer Amicus Therapeutics and a board member of the Biotechnology Innovation Organization, will become the trade organization’s new president ...

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio,” or the “Company”), a clinical-stage biotechnology company developing ...